Progyny, Inc. (PGNY) stock
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/304% above fair value
$36.71−0.44 (-1.18%)
Close on Nov 17, 2026Market cap $2.82BP/E 39.9Yield –
Progyny operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Progyny's operating income for the twelve months ending Jun 30, 2026 was $112.13M, up 46.1% year over year. For fiscal 2025 it was $85.28M, up 26.4% from the year before. The highest annual figure on record is $85.28M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.28M | +26.4% |
| FY2024 | Dec 31, 2024 | $67.46M | +8.5% |
| FY2023 | Dec 31, 2023 | $62.18M | +166.4% |
| FY2022 | Dec 31, 2022 | $23.34M | -27.8% |
| FY2021 | Dec 31, 2021 | $32.34M | +287.4% |
| FY2020 | Dec 31, 2020 | $8.35M | -13.7% |
| FY2019 | Dec 31, 2019 | $9.68M | – |
| FY2018 | Dec 31, 2018 | -$3.45M | – |
| FY2017 | Dec 31, 2017 | -$11.01M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $40.00M | +64.2% |
| Q1 FY2026 | Mar 31, 2026 | $35.38M | +46.4% |
| Q4 FY2025 | Dec 31, 2025 | $15.22M | -3.6% |
| Q3 FY2025 | Sep 30, 2025 | $21.53M | +72.8% |
| Q2 FY2025 | Jun 30, 2025 | $24.36M | +17.7% |
| Q1 FY2025 | Mar 31, 2025 | $24.17M | +30.5% |
| Q4 FY2024 | Dec 31, 2024 | $15.79M | +14.4% |
| Q3 FY2024 | Sep 30, 2024 | $12.46M | -31.5% |
| Q2 FY2024 | Jun 30, 2024 | $20.69M | +36.2% |
| Q1 FY2024 | Mar 31, 2024 | $18.52M | +23.4% |
| Q4 FY2023 | Dec 31, 2023 | $13.80M | +317.4% |
| Q3 FY2023 | Sep 30, 2023 | $18.19M | +61.6% |
| Q2 FY2023 | Jun 30, 2023 | $15.18M | +71.8% |
| Q1 FY2023 | Mar 31, 2023 | $15.01M | – |
| Q4 FY2022 | Dec 31, 2022 | $3.31M | – |
| Q3 FY2022 | Sep 30, 2022 | $11.26M | +24.2% |
| Q2 FY2022 | Jun 30, 2022 | $8.84M | -24.2% |
| Q1 FY2022 | Mar 31, 2022 | -$58.00K | -100.5% |
| Q4 FY2021 | Dec 31, 2021 | -$188.00K | -116.2% |
| Q3 FY2021 | Sep 30, 2021 | $9.07M | +87.8% |
| Q2 FY2021 | Jun 30, 2021 | $11.66M | – |
| Q1 FY2021 | Mar 31, 2021 | $11.81M | +244.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.16M | +1.5% |
| Q3 FY2020 | Sep 30, 2020 | $4.83M | +57.3% |
| Q2 FY2020 | Jun 30, 2020 | -$1.07M | -145.5% |
| Q1 FY2020 | Mar 31, 2020 | $3.43M | +10.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.14M | – |
| Q3 FY2019 | Sep 30, 2019 | $3.07M | – |
| Q2 FY2019 | Jun 30, 2019 | $2.35M | – |
| Q1 FY2019 | Mar 31, 2019 | $3.11M | – |
| Q4 FY2018 | Dec 31, 2018 | -$703.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$587.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$317.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.85M | – |
See a number that looks wrong?